 | • レポートコード：GIR-22F19309 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Eye Drops for Glaucoma Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の緑内障用点眼薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 緑内障用点眼薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・ビマトプロスト、ラタノプロスト、タフルプロスト、トラボプロスト アプリケーション別セグメントは次のように区分されます。 ・病院、眼科、薬局、その他 世界の緑内障用点眼薬市場の主要な市場プレーヤーは以下のとおりです。 ・Thea Pharmaceuticals Ltd、FDC International Ltd、Martindale Pharma、Zentiva、Upjohn UK Limited、Beacon Pharmaceuticals、Novartis Pharmaceuticals UK Ltd、Mylan、Accord Healthcare Limited、Sandoz Limited、Thornton & Ross Ltd、Aspire Pharma Ltd、AbbVie Ltd 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、緑内障用点眼薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な緑内障用点眼薬メーカーの企業概要、2019年～2022年までの緑内障用点眼薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な緑内障用点眼薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別緑内障用点眼薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの緑内障用点眼薬のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での緑内障用点眼薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および緑内障用点眼薬の産業チェーンを掲載しています。 ・第13、14、15章では、緑内障用点眼薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 緑内障用点眼薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：ビマトプロスト、ラタノプロスト、タフルプロスト、トラボプロスト - アプリケーション別分析（2017年vs2021年vs2028年）：病院、眼科、薬局、その他 - 世界の緑内障用点眼薬市場規模・予測 - 世界の緑内障用点眼薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Thea Pharmaceuticals Ltd、FDC International Ltd、Martindale Pharma、Zentiva、Upjohn UK Limited、Beacon Pharmaceuticals、Novartis Pharmaceuticals UK Ltd、Mylan、Accord Healthcare Limited、Sandoz Limited、Thornton & Ross Ltd、Aspire Pharma Ltd、AbbVie Ltd ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：ビマトプロスト、ラタノプロスト、タフルプロスト、トラボプロスト ・アプリケーション別分析2017年-2028年：病院、眼科、薬局、その他 ・緑内障用点眼薬の北米市場分析 - 緑内障用点眼薬の北米市場：タイプ別市場規模2017年-2028年 - 緑内障用点眼薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・緑内障用点眼薬のヨーロッパ市場分析 - ：緑内障用点眼薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：緑内障用点眼薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・緑内障用点眼薬のアジア太平洋市場分析 - 緑内障用点眼薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 緑内障用点眼薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・緑内障用点眼薬の南米市場分析 - 緑内障用点眼薬の南米市場：タイプ別市場規模2017年-2028年 - 緑内障用点眼薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・緑内障用点眼薬の中東・アフリカ市場分析 - 緑内障用点眼薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 緑内障用点眼薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Eye Drops for Glaucoma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Eye Drops for Glaucoma market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Eye Drops for Glaucoma global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Bimatoprost segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Eye Drops for Glaucoma include Thea Pharmaceuticals Ltd, FDC International Ltd, Martindale Pharma, Zentiva, and Upjohn UK Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Eye Drops for Glaucoma market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bimatoprost
Latanoprost
Tafluprost
Travoprost
Market segment by Application can be divided into
Hospital
Ophthalmic Clinic
Pharmacy
Others
The key market players for global Eye Drops for Glaucoma market are listed below:
Thea Pharmaceuticals Ltd
FDC International Ltd
Martindale Pharma
Zentiva
Upjohn UK Limited
Beacon Pharmaceuticals
Novartis Pharmaceuticals UK Ltd
Mylan
Accord Healthcare Limited
Sandoz Limited
Thornton & Ross Ltd
Aspire Pharma Ltd
AbbVie Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eye Drops for Glaucoma product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Eye Drops for Glaucoma, with price, sales, revenue and global market share of Eye Drops for Glaucoma from 2019 to 2022.
Chapter 3, the Eye Drops for Glaucoma competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eye Drops for Glaucoma breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Eye Drops for Glaucoma market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Eye Drops for Glaucoma.
Chapter 13, 14, and 15, to describe Eye Drops for Glaucoma sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Eye Drops for Glaucoma Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Eye Drops for Glaucoma Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Bimatoprost
1.2.3 Latanoprost
1.2.4 Tafluprost
1.2.5 Travoprost
1.3 Market Analysis by Application
1.3.1 Overview: Global Eye Drops for Glaucoma Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Ophthalmic Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Global Eye Drops for Glaucoma Market Size & Forecast
1.4.1 Global Eye Drops for Glaucoma Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Eye Drops for Glaucoma Sales in Volume (2017-2028)
1.4.3 Global Eye Drops for Glaucoma Price (2017-2028)
1.5 Global Eye Drops for Glaucoma Production Capacity Analysis
1.5.1 Global Eye Drops for Glaucoma Total Production Capacity (2017-2028)
1.5.2 Global Eye Drops for Glaucoma Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Eye Drops for Glaucoma Market Drivers
1.6.2 Eye Drops for Glaucoma Market Restraints
1.6.3 Eye Drops for Glaucoma Trends Analysis
2 Manufacturers Profiles
2.1 Thea Pharmaceuticals Ltd
2.1.1 Thea Pharmaceuticals Ltd Details
2.1.2 Thea Pharmaceuticals Ltd Major Business
2.1.3 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product and Services
2.1.4 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 FDC International Ltd
2.2.1 FDC International Ltd Details
2.2.2 FDC International Ltd Major Business
2.2.3 FDC International Ltd Eye Drops for Glaucoma Product and Services
2.2.4 FDC International Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Martindale Pharma
2.3.1 Martindale Pharma Details
2.3.2 Martindale Pharma Major Business
2.3.3 Martindale Pharma Eye Drops for Glaucoma Product and Services
2.3.4 Martindale Pharma Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Zentiva
2.4.1 Zentiva Details
2.4.2 Zentiva Major Business
2.4.3 Zentiva Eye Drops for Glaucoma Product and Services
2.4.4 Zentiva Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Upjohn UK Limited
2.5.1 Upjohn UK Limited Details
2.5.2 Upjohn UK Limited Major Business
2.5.3 Upjohn UK Limited Eye Drops for Glaucoma Product and Services
2.5.4 Upjohn UK Limited Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Beacon Pharmaceuticals
2.6.1 Beacon Pharmaceuticals Details
2.6.2 Beacon Pharmaceuticals Major Business
2.6.3 Beacon Pharmaceuticals Eye Drops for Glaucoma Product and Services
2.6.4 Beacon Pharmaceuticals Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis Pharmaceuticals UK Ltd
2.7.1 Novartis Pharmaceuticals UK Ltd Details
2.7.2 Novartis Pharmaceuticals UK Ltd Major Business
2.7.3 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product and Services
2.7.4 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Eye Drops for Glaucoma Product and Services
2.8.4 Mylan Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Accord Healthcare Limited
2.9.1 Accord Healthcare Limited Details
2.9.2 Accord Healthcare Limited Major Business
2.9.3 Accord Healthcare Limited Eye Drops for Glaucoma Product and Services
2.9.4 Accord Healthcare Limited Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sandoz Limited
2.10.1 Sandoz Limited Details
2.10.2 Sandoz Limited Major Business
2.10.3 Sandoz Limited Eye Drops for Glaucoma Product and Services
2.10.4 Sandoz Limited Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Thornton & Ross Ltd
2.11.1 Thornton & Ross Ltd Details
2.11.2 Thornton & Ross Ltd Major Business
2.11.3 Thornton & Ross Ltd Eye Drops for Glaucoma Product and Services
2.11.4 Thornton & Ross Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Aspire Pharma Ltd
2.12.1 Aspire Pharma Ltd Details
2.12.2 Aspire Pharma Ltd Major Business
2.12.3 Aspire Pharma Ltd Eye Drops for Glaucoma Product and Services
2.12.4 Aspire Pharma Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 AbbVie Ltd
2.13.1 AbbVie Ltd Details
2.13.2 AbbVie Ltd Major Business
2.13.3 AbbVie Ltd Eye Drops for Glaucoma Product and Services
2.13.4 AbbVie Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Eye Drops for Glaucoma Breakdown Data by Manufacturer
3.1 Global Eye Drops for Glaucoma Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Eye Drops for Glaucoma Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Eye Drops for Glaucoma
3.4 Market Concentration Rate
3.4.1 Top 3 Eye Drops for Glaucoma Manufacturer Market Share in 2021
3.4.2 Top 6 Eye Drops for Glaucoma Manufacturer Market Share in 2021
3.5 Global Eye Drops for Glaucoma Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Eye Drops for Glaucoma Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Eye Drops for Glaucoma Market Size by Region
4.1.1 Global Eye Drops for Glaucoma Sales in Volume by Region (2017-2028)
4.1.2 Global Eye Drops for Glaucoma Revenue by Region (2017-2028)
4.2 North America Eye Drops for Glaucoma Revenue (2017-2028)
4.3 Europe Eye Drops for Glaucoma Revenue (2017-2028)
4.4 Asia-Pacific Eye Drops for Glaucoma Revenue (2017-2028)
4.5 South America Eye Drops for Glaucoma Revenue (2017-2028)
4.6 Middle East and Africa Eye Drops for Glaucoma Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Eye Drops for Glaucoma Sales in Volume by Type (2017-2028)
5.2 Global Eye Drops for Glaucoma Revenue by Type (2017-2028)
5.3 Global Eye Drops for Glaucoma Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Eye Drops for Glaucoma Sales in Volume by Application (2017-2028)
6.2 Global Eye Drops for Glaucoma Revenue by Application (2017-2028)
6.3 Global Eye Drops for Glaucoma Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Eye Drops for Glaucoma Sales by Type (2017-2028)
7.2 North America Eye Drops for Glaucoma Sales by Application (2017-2028)
7.3 North America Eye Drops for Glaucoma Market Size by Country
7.3.1 North America Eye Drops for Glaucoma Sales in Volume by Country (2017-2028)
7.3.2 North America Eye Drops for Glaucoma Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Eye Drops for Glaucoma Sales by Type (2017-2028)
8.2 Europe Eye Drops for Glaucoma Sales by Application (2017-2028)
8.3 Europe Eye Drops for Glaucoma Market Size by Country
8.3.1 Europe Eye Drops for Glaucoma Sales in Volume by Country (2017-2028)
8.3.2 Europe Eye Drops for Glaucoma Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Eye Drops for Glaucoma Sales by Type (2017-2028)
9.2 Asia-Pacific Eye Drops for Glaucoma Sales by Application (2017-2028)
9.3 Asia-Pacific Eye Drops for Glaucoma Market Size by Region
9.3.1 Asia-Pacific Eye Drops for Glaucoma Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Eye Drops for Glaucoma Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Eye Drops for Glaucoma Sales by Type (2017-2028)
10.2 South America Eye Drops for Glaucoma Sales by Application (2017-2028)
10.3 South America Eye Drops for Glaucoma Market Size by Country
10.3.1 South America Eye Drops for Glaucoma Sales in Volume by Country (2017-2028)
10.3.2 South America Eye Drops for Glaucoma Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Eye Drops for Glaucoma Sales by Type (2017-2028)
11.2 Middle East & Africa Eye Drops for Glaucoma Sales by Application (2017-2028)
11.3 Middle East & Africa Eye Drops for Glaucoma Market Size by Country
11.3.1 Middle East & Africa Eye Drops for Glaucoma Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Eye Drops for Glaucoma and Key Manufacturers
12.2 Manufacturing Costs Percentage of Eye Drops for Glaucoma
12.3 Eye Drops for Glaucoma Production Process
12.4 Eye Drops for Glaucoma Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Eye Drops for Glaucoma Typical Distributors
13.3 Eye Drops for Glaucoma Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer